Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
James B Morrissey
Advertisement
James B Morrissey is bioengineering scientist-Cocoon Program, Octane Biotech Inc.
Articles by James B Morrissey
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
4
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
5
